Streamline Health® Improves Liquidity Position and Appoints New Directors

Streamline expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of$15.5 million of installed SaaS ARR during the second half of fiscal 2024 Expanded board of directors with appointment of CEO Benjamin Stilwill and Matthew EtheridgeClosed private placement of unsecured subordinated notes and warrants and private placement of common stock resulting in aggregate gross proceeds of approximately $4.5 millionModified existing senior loan covenants ...